When your formulation IP is beyond compare (T 0722/24)

The recent decision in T 0722/24 is an example of effective patent strategy for a clinical stage product. Pharmaceutical innovation involves far more than identification of a therapeutic molecule. Over the course of a drug's life cycle, there is the need for considerable and lengthy further development, leading to new inventions. This innovation leads to new patentable inventions,